Live Breaking News & Updates on Tourmaline Bio

Stay updated with breaking news from Tourmaline bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TRML Stock Earnings: Tourmaline Bio Beats EPS for Q1 2024

TRML Stock Earnings: Tourmaline Bio Beats EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Tourmaline Bio , Place Earnings ,

Vivo Capital LLC Purchases Shares of 591,882 Tourmaline Bio, Inc. (NASDAQ:TRML)

Vivo Capital LLC Purchases Shares of 591,882 Tourmaline Bio, Inc. (NASDAQ:TRML)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Jefferies Financial Group , Tourmaline Bio Inc , Vivo Capital , Capital Management , Securities Exchange Commission , Tourmaline Bio , Free Report , Get Free Report , Visit Holdingschannel , Tourmaline Bio Daily ,

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Rating of "Buy" from Brokerages

Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Rating of "Buy" from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Mark Mcdade , Capital Management , Tourmaline Bio Inc , Denali Advisors , Affinity Asset Advisors , Jump Financial , Securities Exchange Commission , Jefferies Financial Group , Tourmaline Bio , Get Free Report , Financial Group , Director Mark Mcdade , Exchange Commission , Asset Advisors , Get Free , Tourmaline Bio Daily ,

Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Rating of "Buy" by Analysts

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have updated their coverage on the stock in the last […] ....

Mark Mcdade , Jefferies Financial Group , Capital Management , Denali Advisors , Affinity Asset Advisors , Tourmaline Bio Inc , Jump Financial , Tourmaline Bio , Get Free Report , Financial Group , Truist Financial , Director Mark Mcdade , Asset Advisors , Get Free , Tourmaline Bio Daily , Nasdaq Trml ,